COMPANY OVERVIEW

ENYO Pharma is a privately held biopharmaceutical company with an innovative approach inspired by viruses.

---

LOCATION

Lyon, , France

---

THERAPEUTIC AREAS

Infectious Disease

---

WEBSITE

https://www.enyopharma.com/

---

CAREER WEBSITE

https://www.enyopharma.com/contact/careers/

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Nov 3, 2021

ENYO Pharma Announces Two Vonafexor Data Presentations at AASLD The Liver Meeting

Aug 11, 2021

2021 Pipeline Insights on Chronic Hepatitis B Virus Infections - Featuring Arbutus Biopharma, Enyo Pharma and Gilead Sciences Among Others - ResearchAndMarkets.com

Jul 30, 2021

ENYO Pharma Announces 16 Weeks Vonafexor (EYP001) Top-Line Interim Results from Two on-going Phase 2a Studies in Chronic Hepatitis B Patients

Jul 28, 2021

ENYO Pharma Announces Positive Vonafexor (EYP001) Results for the LIVIFY Phase 2a Study in F2-F3 NASH Patients over 12 weeks

Oct 17, 2019

ENYO Pharma Announces Multiple EYP001 Data Presentations At AASLD Conference

For More Press Releases

---